Leap Therapeutics
LPTX
#9126
Rank
ยฃ86.8 M
Marketcap
ยฃ1.53
Share price
368.57%
Change (1 day)
-38.03%
Change (1 year)

Revenue for Leap Therapeutics (LPTX)

Revenue in 2025 (TTM): N/A

In 2024 the company made a revenue of N/A a decrease over the revenue in the year 2023 that were of N/A. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Leap Therapeutics from 2013 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) N/A
2024 N/A
2023 N/A
2022 N/A-100%
2021 ยฃ1.11 M0.98%
2020 ยฃ1.1 M
2019 N/A
2018 N/A
2017 N/A
2016 N/A
2015 N/A
2014 N/A
2013 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
ORIC Pharmaceuticals
ORIC
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA